Oscare Medical Oy
Oscare Medical’s compact, handheld device for osteoporosis screening promotes early detection of osteoporosis, leading to better bone health and better life. The device is the end-result of 10 years of research, which started at the University of Jyväskylä, Finland. Encouraged by excellent and promising results, Oscare Medical was founded in 2007 to commercialize the results of the university research.
The product got CE marking in 2013 and currently OsCare Sono® is available in several European and Middle-Eastern markets through distributors. Oscare Medical is developing a worldwide distribution network over the coming years, and aims for a significant market share in the expanding bone health assessment market.
Revenio Group Corporation, a Finnish health technology group listed in the Helsinki stock exchange, owns the majority of Vantaa based Oscare Medical’s shares. The board members and management share a wide-ranging experience in the areas of medical product development, manufacturing, quality control, as well as in domestic and international sales and marketing.